Beijing, China
Research view
Hepatitis B: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Filter by target, by country, or show only institutions in EU-13 (Horizon Europe widening) countries.
EU-13 is a filter, not a ranking: it only narrows the list.
Shanghai, China
Paris, France
Guangzhou, China
Beijing, China
Hangzhou, China
Fuzhou, China
Pok Fu Lam, Hong Kong
Beijing, China
Guangzhou, China
Shanghai, China
Guangzhou, China
Beijing, China
Chengdu, China
Chengdu, China
Nanjing, China
Beijing, China
Cambridge, United States
Hanover, Germany
Nanjing, China
Chongqing, China
Hangzhou, China
Stanford, United States
Stanford, United States
24 of 200+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
“Liquidation of MagIA Diagnostics”Registry text, quoted unchanged. Source
Withdrawn
PREHEVBRIO Pregnancy Outcomes Registry
“Company out of business”Registry text, quoted unchanged. Source
Terminated
HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers
“The yield of cells recovered from the lymph node fine needle aspirations was low limiting the ability to perform the planned immunologic assessments following HBV vaccination.”Registry text, quoted unchanged. Source
Terminated
“The Sponsor decided to discontinue the development of RO7565020 and as a result the BP44118 study was terminated.”Registry text, quoted unchanged. Source
Terminated
HepTcell Immunotherapy in Patients With Inactive Chronic Hepatitis B (CHB)
“Did not meet endpoints”Registry text, quoted unchanged. Source
Terminated
An Observational Study of Patients With Chronic Hepatitis B (CHB) Infection
“Study Closure”Registry text, quoted unchanged. Source
Withdrawn
“Per sponsor request. Premature closure was not prompted by any safety or efficacy concerns.”Registry text, quoted unchanged. Source
Withdrawn
“Sponsor Decision after re-evaluation of strategy in the context of recruitment timelines projection”Registry text, quoted unchanged. Source
Withdrawn
Immunogenicity and Safety of DTP-HB-Hib Using New Hepatitis B Bulk (Bio Farma)
“The products will be replace with others.”Registry text, quoted unchanged. Source
Terminated
“low enrollment rate”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 12
- Organoids 3
- Mendelian Randomization Analysis 7
- CRISPR-Cas Systems 23
- Gene Expression Profiling 26
- Sequence Analysis, RNA 2
- Whole Genome Sequencing 2
- Exome Sequencing 1
- Proteomics 8
- Metabolomics 10
- Mass Spectrometry 2
- Flow Cytometry 3
- Immunohistochemistry 4
- Liquid Biopsy 2
- Xenograft Model Antitumor Assays 2
- Magnetic Resonance Imaging 22
- Machine Learning 38
- Deep Learning 6
- Cohort Studies 62
- Genome-Wide Association Study 12
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed. Machine-matched links are labelled.